|Articles|November 1, 2017
Almac Group Announces Acquisition of BioClin Laboratories
Advertisement
Almac Group announced the acquisition of 100% shares of BioClin Laboratories. BioClin will bring fourth its expert analytical services and analysis to increase Almac’s capacity and compliment its existing business strategic expansion which will help them to serve clients globally.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Meeting Halfway: Co-Developing Frameworks for Seamless FSO to FSP Transitions
2
SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D
3
SCOPE Summit 2026: ESG Shifts From Reporting Exercise to Vendor Readiness Test in Clinical Operations
4
Regulatory Uncertainty Emerges Across the Drug Development Lifecycle
5